Related Experiment Video
Updated: Jul 19, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Nucleus-localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG
Meiliang Liu1,2, Mingshuang Lai1,2, Deyuan Li1,2
1Department of Epidemiology and Health Statistics, School of Public Health, Guangxi Medical University, Nanning, China.
Abstract:
Accumulating evidence indicates that circular RNAs (circRNAs) are inextricably linked to cancer development. However, the function and mechanism of nucleus-localized circRNAs in hepatocellular carcinoma (HCC) still require investigation. Here, qRT-PCR and receiver-operating characteristic curve were used to detect the expression and diagnostic potential of circSLC39A5 for HCC. The biological function of circSLC39A5 in HCC was investigated in vitro and in vivo. Nucleoplasmic separation assay, fluorescence in situ hybridization, RNA pulldown, RNA immunoprecipitation, the HDOCK Server, the NucleicNet Webserver, crosslinking-immunoprecipitation, MG132 treatment, and chromatin immunoprecipitation were utilized to explore the potential molecular mechanism of circSLC39A5 in HCC. The results showed that circSLC39A5 was downregulated in both HCC tissues and plasma and was associated with satellite nodules and lymph node metastasis/vascular invasion. CircSLC39A5 was stably expressed in plasma samples under different storage conditions, showing good diagnostic potential for HCC (AUC = 0.915). CircSLC39A5 inhibited proliferation, migration, and invasion, facilitated the apoptosis of HCC cells, and was associated with low expression of Ki67 and CD34. Remarkably, circSLC39A5 is mainly localized in the nucleus and binds to the transcription factor signal transducer and activator of transcription 1 (STAT1), affecting its stabilization and expression. STAT1 binds to the promoter of thymine DNA glycosylase (TDG). Overexpression of circSLC39A5 elevates TDG expression and reverses the increase of proliferating cell nuclear antigen (PCNA) expression and the overactive cell proliferation caused by TDG silencing. Our findings uncovered a novel plasma circRNA, circSLC39A5, which may be a potential circulating diagnostic marker for HCC, and the mechanism by which nucleus-localized circSLC39A5 exerts a transcriptional regulatory role in HCC by affecting STAT1/TDG/PCNA provides new insights into the mechanism of circRNAs.
Insights
Circular RNA circSLC39A5 is downregulated in hepatocellular carcinoma (HCC) and acts as a potential diagnostic marker. This nucleus-localized circular RNA inhibits HCC progression by regulating the STAT1/TDG/PCNA pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer development.
- The specific functions and mechanisms of nuclear-localized circRNAs in hepatocellular carcinoma (HCC) remain largely unexplored.
Purpose of the Study:
- To investigate the expression, diagnostic value, and functional mechanism of circSLC39A5 in HCC.
- To elucidate the role of nuclear circSLC39A5 in regulating HCC cell behavior and gene expression.
Main Methods:
- Quantitative reverse transcription-PCR (qRT-PCR) and receiver-operating characteristic (ROC) curve analysis for expression and diagnosis.
- In vitro and in vivo experiments to assess biological function.
- Nucleoplasmic separation, FISH, RNA pulldown, RIP, HDOCK, NucleicNet, CLIP, MG132 treatment, and ChIP to explore molecular mechanisms.
Main Results:
- circSLC39A5 was significantly downregulated in HCC tissues and plasma, correlating with metastasis.
- circSLC39A5 demonstrated high diagnostic potential for HCC (AUC=0.915) and stability in plasma.
- circSLC39A5 inhibited HCC proliferation, migration, and invasion, while promoting apoptosis, by interacting with STAT1 to regulate TDG/PCNA expression.
Conclusions:
- circSLC39A5 is a potential circulating biomarker for HCC diagnosis.
- Nuclear circSLC39A5 plays a tumor-suppressive role in HCC through the STAT1/TDG/PCNA pathway, offering novel mechanistic insights.
More Related Videos
04:26Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
09:13Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
Published on: October 24, 2016
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Cell Specific Gene Expression